Vestcor Inc United Therapeutics Corp Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Vestcor Inc holds 1,004 shares of UTHR stock, worth $378,508. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,004

Previous 1,004 -0.0%

Holding current value

$378,508

Previous $320,000 12.5%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $1,686 - $1,996	-8 Reduced 0.79%	1,004 $231,000
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $2,148 - $2,569	-10 Reduced 0.98%	1,012 $223,000
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $217,675 - $282,245	1,022 New	1,022 $229,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $108,170 - $139,287	-651 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$184.32 - $216.08 $13,455 - $15,773	-73 Reduced 10.08%	651 $141,000
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $1.02 Million - $1.22 Million	-5,674 Reduced 88.68%	724 $134,000
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $14,830 - $18,437	-87 Reduced 1.34%	6,398 $1.15 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $536,788 - $609,701	-3,487 Reduced 34.97%	6,485 $1.09 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $1.83 Million - $2.72 Million	-17,921 Reduced 64.25%	9,972 $1.51 Million
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $352,746 - $427,710	-3,531 Reduced 11.24%	27,893 $2.82 Million
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $2.91 Million - $3.95 Million	31,424 New	31,424 $3.8 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account